Survival of Advanced Stage High-Grade Serous Ovarian Cancer Patients in the Republic of Macedonia (original) (raw)

Examining Survival Outcomes of 852 Women With Advanced Ovarian Cancer: A Multi-institutional Cohort Study

Jacob McGee

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2018

View PDFchevron_right

Survival rates among women with ovarian cancers diagnosed in the area of Podkarpacie province in the years 1990–2015

Sebastian Wójcik

Współczesna Onkologia, 2018

View PDFchevron_right

Epithelial ovarian cancer in Greece: a retrospective study of 1,791 patients by the Hellenic Cooperative Oncology Group (HeCOG)

G. Papaxoinis

Anticancer research, 2009

View PDFchevron_right

A survival analysis of ovarian low-grade serous carcinoma

Dove Medical Press

2014

View PDFchevron_right

Impact of lymph node ratio on survival in stage III ovarian high-grade serous cancer: a Turkish Gynecologic Oncology Group study

Hüsnü Çelik

Journal of Gynecologic Oncology, 2018

View PDFchevron_right

The prognostic factors of survival and recurrence in patients with serous ovarian and uterine cancers treated in a single institution for 17 years

Mehmet Gokcu

Current Gynecologic Oncology

View PDFchevron_right

A retrospective study on ovarian cancer with a median follow-up of 36 months at Bejaïa University Hospital

IJAERS Journal

View PDFchevron_right

A binary histologic grading system for ovarian serous carcinoma is an independent prognostic factor: A population-based study of 4317 women diagnosed in Denmark 1978–2006

Jette Junge

Gynecologic Oncology, 2012

View PDFchevron_right

Evaluation of clinical characteristics linked with the survival of patients with advanced-stage ovarian malignancies

Milan Terzic

Journal of B.U.ON. : official journal of the Balkan Union of Oncology, 2017

View PDFchevron_right

Prognostic factors in advanced epithelial ovarian cancer. (Gruppo Interregionale Cooperativo di Oncologia Ginecologica (GICOG))

Valter Torri

British journal of cancer, 1990

View PDFchevron_right

Factors determining ultra-short-term survival and the commencement of active treatment in high-grade serous ovarian cancer: a case comparison study

Kay Gee

BMC Cancer, 2021

View PDFchevron_right

Prognostic Factors Affecting Survival in Patients with Ovarian Cancer: A 5-Year Experience in an University Hospital

Gul Pinar

International Journal of Hematology and Oncology, 2017

View PDFchevron_right

Clinical-pathological presentation, treatment and outcomes of ovarian cancer cases at moi teaching and referral hospital (mtrh), eldoret

Vincent 5 oyiengo

Journal of Obstetrics & Gynaecology of Eastern and Central Africa, 2019

View PDFchevron_right

Time Trends in Ovarian Cancer Survival in Estonia by Age and Stage

Piret Veerus

International Journal of Gynecological Cancer, 2016

View PDFchevron_right

Real-World Data on Treatment Management and Outcomes of Patients with Newly Diagnosed Advanced Epithelial Ovarian Cancer in Greece (The EpOCa Study)

G. Aravantinos

Current Oncology

View PDFchevron_right

Validation of a New Prognostic Score in Patients with Ovarian Adenocarcinoma

Laurentia Gales

Medicina

View PDFchevron_right

Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)

G. Launoy

Gynecologic oncology, 2017

View PDFchevron_right

The Clinicopathologic Characteristics and 5-year Survival Rate of Epithelial Ovarian Cancer in Yazd, Iran

Pouria Yazdian-Anari

View PDFchevron_right

Ovarian cancer stages I and II: Predictions and 5-year survival in two decades

Seth Granberg

Gynecologic Oncology, 1989

View PDFchevron_right

Ovarian cancer: changes in patterns at diagnosis and relative survival over the last three decades

John Malone

American Journal of Obstetrics and Gynecology, 2003

View PDFchevron_right

Management of Ovarian Cancer: Experience of a single Institution

Enas A Elkhouly

Research in Oncology, 2014

View PDFchevron_right

The prediction of progression-free and overall survival in women with an advanced stage of epithelial ovarian carcinoma

Curt Burger

BJOG: An International Journal of Obstetrics & Gynaecology, 2009

View PDFchevron_right

Outcome of epithelial ovarian cancer in women under 40 years of age treated with platinum-based chemotherapy

Marta Miranda

European Journal of Cancer, 1999

View PDFchevron_right

Patterns and Progress in Ovarian Cancer Over 14 Years

Nelson Teng

Obstetrics & Gynecology, 2006

View PDFchevron_right

Aetiology, Epidemiology, Histopathology, Classification, Detailed Evaluation, and Treatment of Ovarian Cancer

Ashish Anjankar

Cureus, 2022

View PDFchevron_right

The prognostic value of clinical, pathologic, and biologic parameters in ovarian cancer

Soo Khoo

Cancer, 1993

View PDFchevron_right

A Population-Based Survey of Ovarian Malignancies in the Southeast Health Care Region of Sweden 1984–1987

Thomas Hogberg

2009

View PDFchevron_right

Comparison of survival outcomes in optimally and maximally cytoreduced stage IIIC ovarian high‐grade serous carcinoma: Women with only peritoneal tumor burden versus women with both peritoneal and lymphogenous dissemination

Hüsnü Çelik

Journal of Obstetrics and Gynaecology Research, 2019

View PDFchevron_right

Clinical Therapeutic and Prognostic Aspects of Ovarian Adenocarcinomas Followed by the Medical Oncology Department of Bejaia University Hospital

Chahira MAZOUZI Epse DJAHNINE

International Journal For Multidisciplinary Research, 2023

View PDFchevron_right

Ovarian cancer (advanced)

Sean Kehoe

BMJ clinical evidence, 2009

View PDFchevron_right

Oncological and surgical characteristics of patients with ovarian cancer diagnosed in the main multidisciplinary hospital in Romania

Alexandru Baros, Alina Potorac

Practica medicală, 2021

View PDFchevron_right